Innate Pharma SA annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Innate Pharma SA Revenue Growth & History (IPHA)
Innate Pharma SA reported €9.0M in revenue for fiscal 2025, a decrease of 55.25% from the previous fiscal year.
View full Innate Pharma SA company overviewInnate Pharma SA annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €9.0M | −€11.1M | −55.25% |
| 2024 | 2024-12-31 | €20.1M | −€41.5M | −67.36% |
| 2023 | 2023-12-31 | €61.6M | €4.0M | +6.88% |
| 2022 | 2022-12-31 | €57.7M | €33.0M | +133.47% |
| 2021 | 2021-12-31 | €24.7M | −€45.1M | −64.60% |
| 2020 | 2020-12-31 | €69.8M | −€15.7M | −18.35% |
| 2019 | 2019-12-31 | €85.4M | −€8.5M | −9.05% |
| 2018 | 2018-12-31 | €94.0M | €49.9M | +113.37% |
| 2017 | 2017-12-31 | €44.0M | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Innate Pharma SA filings at SEC.gov ↗